Biotechnology and medical device start-up EnzySurge has raised $1.7 million in a financing round giving it a value of $7m., the company said Sunday. The financing was led by Eli Gilboa, from investment house Gilboa & Licht with participation from other unnamed private investors.
Enzysurge had raised approximately $2m. in previous financing rounds. EnzySurge said it would use the funds for testing the combination of its first two products - DermaStream used in the treatment of hard-to-heal chronic wounds and EnzyStream, a therapeutic solution for chronic ulcers - in a multi-center clinical study